JP6968141B2
(ja )
2021-11-17
新規ulk1阻害剤およびそれを使用する方法
JP4642309B2
(ja )
2011-03-02
ヒトホスファチジル−イノシトール3−キナーゼデルタの阻害剤
JP4945060B2
(ja )
2012-06-06
人間のホスファチジルイノシトール3−キナーゼデルタの阻害
EP1761540B1
(en )
2016-09-28
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
AU2013364070B2
(en )
2016-10-27
Isoquinolinone or quinazolinone phosphatidylinositol 3-kinase inhibitors
KR20140075693A
(ko )
2014-06-19
헤테로사이클릭 화합물 및 그의 용도
AU2008321099A1
(en )
2009-05-22
Inhibitors of human phosphatidyl-inositol 3-kinase delta
EP3052476A2
(en )
2016-08-10
Substituted nicotinimide inhibitors of btk and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
EA017389B1
(ru )
2012-12-28
Гетероциклические соединения и их применение
WO2014063054A1
(en )
2014-04-24
Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
Methot et al.
2019
Structure overhaul affords a potent purine PI3Kδ inhibitor with improved tolerability
EP3448839B1
(en )
2022-02-09
Quinazoline derivative or its salt and pharmaceutical composition comprising the same
Guo et al.
2023
Discovery of BGB-8035, a Highly Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase for B-Cell Malignancies and Autoimmune Diseases
UA76103C2
(en )
2006-07-17
Inhibitors of phosphatidyl-inositol- 3-kinase delta of human
CN119677732A
(zh )
2025-03-21
双环四氢氮杂䓬衍生物
HK1224674B
(en )
2021-01-29
Inhibitors of human phosphatidyl-inositol 3-kinase delta
HK1236520B
(en )
2022-02-04
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
HK1236520A
(en )
2018-03-29
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
HK1224674A1
(en )
2017-08-25
Inhibitors of human phosphatidyl-inositol 3-kinase delta
HK1053308B
(en )
2011-08-05
Inhibitors of human phosphatidyl-inositol 3-kinase delta
HK1187338A
(en )
2014-04-04
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
HK1105586A1
(en )
2008-02-22
Phthalazine derivatives as parp inhibitors
HK1105586B
(en )
2012-02-24
Phthalazine derivatives as parp inhibitors